AbbVie’s Skin Disease Drug Hits Phase 3 Goal, but Efficacy Falls Short of Benchmarks: Analyst

📅 22/10/2026 18:17 📰 benzinga 👁️ 1 lectures 🌍 États-Unis 📂 Actualités